Form 4 for CL Colgate-Palmolive
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-11 · accession 0001225208-25-007961 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-12 | 2025-09-11 | CL | Hazlin John | Chief Growth Off | A - Grant | $0.00 | +4,045 | 18.5K | +28% | $0 |
| D | 2025-09-12 | 2025-09-11 | CL | Hazlin John | Chief Growth Off | A - Grant | $0.00 | +28.0K | 28.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | A | A | 4,045 | $0.00 | 18,455 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-09-11 | A | A | 28,007 | $0.00 | 28,007 | D | $84.06 · — to 2033-09-11 | 28,007 Common Stock | (F3) Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the September 11, 2025 grant date. |